Yoshihiro Kiyota

Title: Innovations of Yoshihiro Kiyota

Introduction

Yoshihiro Kiyota is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions. With a total of 3 patents to his name, Kiyota's work is recognized for its potential impact on therapeutic treatments.

Latest Patents

Kiyota's latest patents include an amide compound that serves as a FAAH inhibitor. This compound is designed to be used as a prophylactic or therapeutic agent for cerebrovascular disorders or sleep disorders. The formulation includes a complex structure where various groups can be substituted to enhance its efficacy. Another notable patent is a cannabinoid receptor modulator, which contains a compound that interacts with cannabinoid receptors. This modulator is represented by a specific formula that includes an optionally substituted acylamino group and a benzene ring, showcasing Kiyota's innovative approach to drug development.

Career Highlights

Yoshihiro Kiyota is currently associated with Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical company. His work at Takeda emphasizes the importance of research and development in creating effective medical solutions. Kiyota's dedication to innovation in pharmaceuticals has positioned him as a key figure in his field.

Collaborations

Kiyota has collaborated with notable colleagues such as Shigenori Ohkawa and Tetsuya Tsukamoto. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in pharmaceutical science.

Conclusion

Yoshihiro Kiyota's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving medical treatments. His work continues to inspire advancements in therapeutic solutions.